425 related articles for article (PubMed ID: 16538879)
1. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
[TBL] [Abstract][Full Text] [Related]
2. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
4. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
6. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis.
Laster M; Soohoo M; Streja E; Elashoff R; Jernigan S; Langman CB; Norris KC; Salusky IB; Kalantar-Zadeh K
Pediatr Nephrol; 2019 Jan; 34(1):107-115. PubMed ID: 30267239
[TBL] [Abstract][Full Text] [Related]
7. Correlation among markers of renal osteodystrophy in pediatric hemodialysis patients.
Piscitelli J; Cabansag MR; Silverstein DM
J Pediatr Endocrinol Metab; 1999; 12(6):879-86. PubMed ID: 10614547
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
9. Measurement of PTH fragments for assessment of renal bone disease in hemodialysis patients.
Fehr T; Garzoni D; Staub T; Binet I; Wüthrich RP
Kidney Blood Press Res; 2006; 29(3):175-81. PubMed ID: 16931896
[TBL] [Abstract][Full Text] [Related]
10. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
Gal-Moscovici A; Popovtzer MM
Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
[TBL] [Abstract][Full Text] [Related]
11. Cultures of human osteoblastic cells from dialysis patients: influence of bone turnover rate on in vitro selection of interleukin-6 and osteoblastic cell makers.
Sánchez MC; Bajo MA; Selgas R; Mate A; Sánchez-Cabezudo MJ; López-Barea F; Esbrit P; Martínez ME
Am J Kidney Dis; 2001 Jan; 37(1):30-37. PubMed ID: 11136164
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
Salusky IB; Ramirez JA; Oppenheim W; Gales B; Segre GV; Goodman WG
Kidney Int; 1994 Jan; 45(1):253-8. PubMed ID: 8127016
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients.
Johansen KL; Chertow GM
J Ren Nutr; 2007 Sep; 17(5):305-13. PubMed ID: 17720099
[TBL] [Abstract][Full Text] [Related]
16. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Greenbaum LA; Grenda R; Qiu P; Restaino I; Wojtak A; Paredes A; Benador N; Melnick JZ; Williams LA; Salusky IB
Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
[TBL] [Abstract][Full Text] [Related]
17. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
Weinreich T; Ritz E; Passlick-Deetjen J
Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients.
Navarro JF; Mora C; Jiménez A; Torres A; Macía M; García J
Am J Kidney Dis; 1999 Jul; 34(1):43-8. PubMed ID: 10401014
[TBL] [Abstract][Full Text] [Related]
19. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
20. Effects of in-center daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients.
Lugon JR; André MB; Duarte ME; Rembold SM; Cruz E
Sao Paulo Med J; 2001 May; 119(3):105-9. PubMed ID: 11391452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
